Not provided
Not provided
Not provided
Not provided
Not provided
Study did not get funded
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There is a growing body of evidence suggesting low water intake and elevated levels of the hormone vasopressin exacerbate glucose regulation. This project will examine the physiological mechanism by which low water intake impairs glucose homeostasis.
In the current proposal we aim to: 1) quantify the degree of glucose impairment as a response to elevated vasopressin due to low water intake and 2) identify the physiological mechanism by which elevated vasopressin, as a response to low water intake, impairs glucose regulation
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High Water intake | Active Comparator | 5-days of High water intake according to IOM guidelines |
|
| Low Water Intake | Experimental | 5-days of Low water intake of 500 mL/day |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Water intake manipulation | Other | for 5 days prior to each experiment subjects will undergo manipulation of their water intake. |
|
| Measure | Description | Time Frame |
|---|---|---|
| amount of glucose metabolized M | amount of glucose metabolized during the euglycemic & Hyperglycemic clamp | 220-240 min & 340-360 min of the protocol |
| metabolic clearance rate for insulin | metabolic clearance rate for insulin during the euglycemic & Hyperglycemic clamp | 220-240 min & 340-360 min of the protocol |
| quantity of glucose metabolized per unit plasma insulin concentration | quantity of glucose metabolized per unit plasma insulin concentration during the euglycemic & Hyperglycemic clamp | 220-240 min & 340-360 min of the protocol |
| Rate of glucose appearance & disappearance | Rate of glucose appearance & disappearance during the euglycemic & Hyperglycemic clamp | 220-240 min & 340-360 min of the protocol |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma copeptin | Plasma copeptin in response to water manipulation | 0 min, 240 min & 360 min of the protocol |
| glucagon | glucagon in response to water manipulation |
Not provided
Inclusion Criteria:
BMI 27.5-35
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D003681 | Dehydration |
| D003919 | Diabetes Insipidus |
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D014883 | Water-Electrolyte Imbalance |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 0 min, 240 min & 360 min of the protocol |
| Cortisol | Cortisol in response to water manipulation | 0 min, 240 min & 360 min of the protocol |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D010900 | Pituitary Diseases |
| D004700 | Endocrine System Diseases |